日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Targeting ATP11B-YAP axis repairs mitochondrial function and inhibits neuronal ferroptosis to attenuate age-related cognitive decline

靶向ATP11B-YAP轴可修复线粒体功能并抑制神经元铁死亡,从而减轻与年龄相关的认知衰退。

Qi, Wenxin; Liu, Qian; Dong, Naijun; Sun, Xiuqiao; Wu, Peiru; Zhou, Jianxin; Sun, Ruiqi; Liu, Yihao; Zhao, Robert Chunhua; Wang, Jiao

Multiomics Mendelian randomization identifies serpin family G member 1 as a chronic obstructive pulmonary disease modulator

多组学孟德尔随机化鉴定出丝氨酸蛋白酶抑制剂家族G成员1是慢性阻塞性肺疾病的调节因子

Yi, Erkang; Cui, Jieda; Wang, Hairong; Wu, Fan; Hong, Qiyang; Li, Qingyang; Xie, Chengshu; Xu, Huahua; Liu, Yu; Ran, Xinru; Wu, Xiaohui; Wan, Qi; Tang, Gaoying; Zhu, Leqing; Pang, Junling; Zhou, Yumin; Long, Erping; Ran, Pixin

Coronary atherosclerotic plaque intervention with Tongxinluo capsule (TXL-CAP): a multicenter, randomized, double-blind and placebo-controlled study

通心络胶囊(TXL-CAP)治疗冠状动脉粥样硬化斑块:一项多中心、随机、双盲、安慰剂对照研究

Ni, Mei; Ti, Yun; Yu, Huai; Zhang, Meng; Qi, Yan; Duan, Dayue Darrel; Xie, Qiang; Ji, Zheng; Zhao, Ranzun; Zhou, Yujie; Chen, Shaoliang; Wang, Lin; Zhang, Yaojun; Guo, Jincheng; He, Yuquan; Yao, Chen; Bu, Peili; Yu, Bo; Zhang, Yun; Zhang, Cheng

DUSP6 ablation restores CAR T-cell fitness impaired by tumor CD58 loss through invigoration of AP-1 signaling

DUSP6 消融可通过增强 AP-1 信号传导来恢复因肿瘤 CD58 丢失而受损的 CAR T 细胞活性。

Ma, Xinran; Zhang, Yang; Wang, Yao; Han, Fuxin; Lu, Yuting; Tong, Chuan; Guo, Yelei; Wei, Jianshu; Zhu, Qi; Dong, Liang; Cao, Zhi; Meng, Zhenzhen; Shi, Jinhong; Wu, Zhiqiang; Han, Weidong

The consensus molecular subtypes of esophageal squamous cell carcinoma

食管鳞状细胞癌的共识分子亚型

Cui, Heyang; Zhu, Zhongxu; Xu, Enwei; Qi, Lin; Cheng, Yikun; Zhang, Yinghan; Zhang, Ling; Cheng, Matthew Yibo; Yang, Bin; Sun, Ruifang; Zhuang, Xiaofei; Xi, Yanfeng; Yan, Ting; Cheng, Caixia; Ding, Ning; Liu, Huijuan; Wang, Lu; Guo, Min; Guo, Dinghe; Zhang, Haoyu; Peng, Meilan; An, Zhekun; Weng, Yongjia; Wang, Fang; Liu, Meng; Xiong, Ruixin; Yin, Weihua; Song, Bin; Zhang, Weimin; Cheng, Xiaolong; Liu, Zhihua; Zhan, Qimin; Wang, Xin; Cui, Yongping

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

PRIME-HFrEF试验:一项针对心力衰竭的随机、双盲、多剂量脐带间充质干细胞治疗方案

Han, Wei; Jiao, Yuheng; Chen, Wei; Gong, Xin; Hu, Hao; Xin, Yuanfeng; Guan, Sibin; Zhao, Jun; Zhang, Qi; Yang, Bing; Pan, Jingwei; Wang, Haiyan; Lu, Qing; Chu, Shuguang; Cai, Dihui; Zheng, Liang; Jia, Wenwen; He, Zhiying; Yang, Huangtian; Sun, Yi Eve; Liu, Zhongmin

Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder

帕金森病伴快速眼动睡眠行为障碍患者的代谢组学和蛋白质组学特征独特

Shao, Yaping; Wang, Jing; Liu, Yaping; Ni, Yang; Liu, Zijiao; Li, Yanli; Jia, Qiqi; Li, Qi; Wang, Xiaolin; Li, Tianbai; Liu, Meichen; Zhang, Shuining; Guo, Yanming; Guo, Xisa; Wang, Dali; Liu, Yang; Liu, Cong; Cai, Huaibin; Ning, Yuping; Zhang, Jihui; Xu, Guowang; Le, Weidong

BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis.

BMX抑制剂通过ERK1/2-Cyclin D1/CDK4/6轴稳定E2F1,从而克服小细胞肺癌的化疗耐药性。

Wu Ting, Qi Shuang, Shi Chenliang, Wu Chao, Liu Qingwang, Hu Chen, Hu Jie, Wang Aoli, Liu Jing, Qi Ziping, Wang Wenchao, Liu Qingsong